NCT06111508View on ClinicalTrials.gov

The Effect and Safety of a Novel CGM-Based Titration Algorithm for Basal Insulin in T2DM Participants.

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 29, 2023

Primary Completion Date

September 13, 2024

Study Completion Date

September 16, 2024

Conditions
Type 2 Diabetes
Interventions
DEVICE

Continuous Glucose Monitoring (CGM)-based titration algorithm implemented in DiAs

A Continuous Glucose Monitoring (CGM)-based once weekly titration algorithm of basal insulin as implemented in DiAs Cloud platform

Trial Locations (2)

10029

Icahn School of Medicine at Mount Sinai, New York

22903

University of Virginia, Charlottesville

Sponsors

Collaborators (1)

Novo Nordisk A/S
All Listed Sponsors
collaborator

Novo Nordisk A/S

INDUSTRY

lead

University of Virginia

OTHER